Share on StockTwits

Stock analysts at Mizuho assumed coverage on shares of National Health Investors (NYSE:NHI) in a report issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating and a $69.00 price target on the stock. Mizuho’s price target suggests a potential upside of 7.13% from the stock’s previous close.

Shares of National Health Investors (NYSE:NHI) opened at 64.05 on Thursday. National Health Investors has a one year low of $53.01 and a one year high of $65.29. The stock has a 50-day moving average of $62.6 and a 200-day moving average of $61.80. The company has a market cap of $2.117 billion and a price-to-earnings ratio of 16.70.

National Health Investors (NYSE:NHI) last released its earnings data on Monday, August 4th. The company reported $0.94 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.05 by $0.11. Analysts expect that National Health Investors will post $4.22 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Monday, November 10th. Investors of record on Tuesday, September 30th will be given a dividend of $0.77 per share. This represents a $3.08 dividend on an annualized basis and a yield of 4.78%. The ex-dividend date of this dividend is Friday, September 26th.

Separately, analysts at Hilliard Lyons upgraded shares of National Health Investors from an “underperform” rating to a “neutral” rating in a research note on Tuesday, August 5th. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $66.83.

National Health Investors, Inc (NYSE:NHI) is a self-managed real estate investment trust (REIT), which invests in income-producing healthcare properties primarily in the long-term care and senior housing industries.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.